AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)

NCT05693142 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
RECRUITING
Status
65
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

REGENXBIO Inc.